The Carlyle Group is to acquire AlpInvest from APG and PGGM through a strategic joint venture with the management of AlpInvest. The transaction will comprise 100% of the share capital of AlpInvest and will enable AlpInvest, APG and PGGM to pursue their own respective multi-client strategies. APG and PGGM will

Intermediate Capital Group (ICG), the FTSE 250 listed investment firm and asset manager with EUR12 billion under management, together with Exponent Private Equity has agreed to finance the acquisition of Premier Foods’ meat free division Marlow Foods for GBP205 million.

 ICG is providing junior debt and equity financing of GBP80

CDC, the UK’s Development Finance Institution, has announced a USD30 million investment in the African Infrastructure Investment Fund 2 (AIIF2), an equity investment fund committed to developing basic infrastructure in Africa.   CDC’s USD30m commitment will help AIIF2 move closer to its target size of USD600m, which it will use

Leading mid-market private equity firm LDC has backed the expansion of eConveyancer, a fast growing provider of software for online conveyancing and home buyer search services, with a significant injection of development capital.   Oxfordshire-based eConveyancer, established in 2003, currently has a two per cent share of the UK online conveyancing

Bunker Hill Capital, a lower middle market buyout fund, has had a final closing on commitments totalling USD200 million for its second fund, Bunker Hill Capital II. New investors in the second fund included a diverse group of limited partners, both domestic and international. “We are thrilled to have such

Independence Equity Management has launched Independence Equity I LP, a venture capital fund that will invest in early-stage companies commercialising technologies that improve resource utilisation.   Today’s announcement follows the first close of capital for the new fund, which will begin making investments this year.  A second close is tentatively

The total value of european private equity deals in 2010 totalled EUR71.5bn, and increase of 143 per cent on 2009, according to Candover’s latest Private Equity Barometer. In the final quarter of 2010 there were 230 private equity-backed deals recorded with a value of EUR22bn, slightly down on the 235

Amgen is to acquire BioVex Inc a portfolio company of Forbion Capital Partners. Biovex Group is a privately held biotechnology company that has two biologics in clinical development, including Biovex’s lead product candidate, OncoVEXGM-CSF, a first in class oncolytic vaccine that may prove to be a paradigm-shifting approach to treating

In 2010, some 2,799 venture deals raised USD26.2 billion, a 6% increase in deals and an 11% increase in capital invested over 2009, when 2,636 deals raised USD23.6 billion, according to Dow Jones VentureSource. And the growth in venture capital investment was driven by capital commitments outside of the Information